Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Renal Cell × temsirolimus × Clear all

Phase

Status

Completed 21 Terminated 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Patients With Advanced or Metastatic Solid Tumors 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1

Interventions

Sunitinib 12 aldesleukin 8 Bevacizumab 6 pembrolizumab 5 pazopanib 5 Nivolumab 5 atezolizumab 4 Interferon-alpha 4 Axitinib 4 Chemotherapy, Adjuvant 3 Blood Specimen Collection 3 sintilimab 2 sargramostim 2 lenvatinib 2 fludarabine phosphate 2 durvalumab 2 camrelizumab 2 cabozantinib 2 avelumab 2 Sorafenib 2 Neoadjuvant Therapy 2 Interferon alpha-2 2 Immunohistochemistry 2 Immune Checkpoint Inhibitors 2 Gene Expression Profiling 2 Fluorouracil 2 Everolimus 2 Cyclophosphamide 2 Amplified Fragment Length Polymorphism Analysis 2 toripalimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01246817 2012-04-11

Temsirolimus-RCC-imaging

Radboud University Medical Center

Phase 2 Unknown

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡